Patient Capital Management 13F, Q4 2024
Samantha McLemore · quarter ending 31 December 2024 · filed 14 February 2025 · SEC CIK 1854794
Common stock only: shares the fund reported owning at the quarter end, valued as filed.
Largest positions, Q4 2024
The 25 largest of 43 positions. Weights are against the whole filed book. Changes are in shares held, against the Q3 2024 filing.
| Company | Ticker | Value | % of book | vs Q3 2024 |
|---|---|---|---|---|
| AMAZON COM INC | AMZN | $133.80M | 6.2% | -3% shares |
| QXO INC | QXO | $122.96M | 5.7% | unchanged |
| ALPHABET INC | GOOGL | $112.73M | 5.2% | unchanged |
| CITIGROUP INC | C | $108.49M | 5.0% | unchanged |
| ENERGY TRANSFER L P | ET | $99.75M | 4.6% | -4% shares |
| META PLATFORMS INC | META | $86.44M | 4.0% | unchanged |
| EXPEDIA GROUP INC | EXPE | $82.44M | 3.8% | -32% shares |
| NVIDIA CORPORATION | NVDA | $81.72M | 3.8% | unchanged |
| GENERAL MTRS CO | GM | $81.56M | 3.8% | unchanged |
| ROYALTY PHARMA PLC | $73.34M | 3.4% | +41% shares | |
| IAC INC | PPLI | $71.93M | 3.3% | unchanged |
| UNITED AIRLS HLDGS INC | UAL | $70.42M | 3.3% | -28% shares |
| ONEMAIN HLDGS INC | OMF | $65.85M | 3.0% | -11% shares |
| SOFI TECHNOLOGIES INC | SOFI | $65.48M | 3.0% | -27% shares |
| SEADRILL 2021 LTD | $65.28M | 3.0% | +64% shares | |
| NORWEGIAN CRUISE LINE HLDG L | $63.91M | 3.0% | -11% shares | |
| BIOGEN INC | BIIB | $63.30M | 2.9% | +62% shares |
| UBS GROUP AG | $61.93M | 2.9% | unchanged | |
| KOSMOS ENERGY LTD | KOS | $58.65M | 2.7% | +82% shares |
| ALIBABA GROUP HLDG LTD | BABA | $58.48M | 2.7% | +5% shares |
| CVS HEALTH CORP | CVS | $58.29M | 2.7% | +69% shares |
| DELTA AIR LINES INC DEL | DAL | $57.32M | 2.6% | -25% shares |
| ILLUMINA INC | ILMN | $54.78M | 2.5% | unchanged |
| DAVE & BUSTERS ENTMT INC | PLAY | $51.88M | 2.4% | +37% shares |
| COINBASE GLOBAL INC | COIN | $50.50M | 2.3% | +15% shares |
What changed since Q3 2024
Against the Q3 2024 filing, Patient Capital Management opened 2 new positions, added to 12, trimmed 14, left 15 unchanged and exited 0. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.
Other quarters
Source: SEC Form 13F-HR, accession 0001085146-25-001553, filed by Patient Capital Management, LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.